Nasdaq · CIK 0001828588
HNVR Hanover Bancorp, Inc. /MD
Insider trading from SEC Form 4. Last filing 40 d ago. Close $24.48 on Oct 9, 2026, +23% from the 52-week low and -12% from the high.
Hanover Bancorp, Inc. /MD (HNVR) has 62 SEC Form 4 filings on file from 16 insiders, the latest filed on Sep 3, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
11 open-market trades have been scored at HNVR. The newest: Robert Golden (director) sold $28k of stock on Feb 5, 2026, filed Feb 9, 2026, scored 20 (weak). The largest of the 11 shown: Robert Golden (director) sold $388k on May 8, 2025, scored 31 (weak). 2 insiders sold within 14 days of each other around Dec 10, 2024.
HNVR closed at $24.48 on Oct 9, 2026, 23% above its 52-week low and 12% below its 52-week high.
5 Form 144 notices of planned sales are on file, the latest filed May 9, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Hanover Bancorp, Inc. /MD, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | Robert Golden director sell | $28k 1,200 shares | -1% | +24% from low-10% from high | |
| 25Weak | Robert Golden director sell | $106k 5,000 shares | -6% | +13% from low-19% from high | |
| 31Weak | Robert Golden director sell | $388k 16,829 shares | -8% | +33% from low-12% from high | |
| 21Weak | Robert Golden director sell | $39k 1,708 shares | -1% | +28% from low-15% from high | |
| 25Weak | Robert Golden director sell | $125k 5,323 shares | -3% | +32% from low-12% from high | |
| 26Weak | Robert Golden director sell | $137k 5,197 shares | -2% | - | |
| 31Weak | Robert Golden director sell | $151k 5,681 shares | -20% | - | |
| 31Weak | Robert Golden director sell | $127k 4,772 shares | -15% | - | |
| 34Weak | Michael David Katz M.D. director sell | $128k 5,000 shares | -3% | - | |
| 31Weak | Robert Golden director sell | $64k 2,500 shares | -8% | - | |
| 10Weak | Elena Sisti director buy | $5,048 215 shares | +0% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 9, 2025 | Golden Robert Director | 5,000 0.07% of outstanding | $114k | May 9, 2025 | $346k |
| May 8, 2025 | Golden Robert Director | 5,000 0.07% of outstanding | $114k | May 5, 2025 | $231k |
| Feb 7, 2025 | Golden Robert Director | 52,771 0.74% of outstanding | $1.4M | Feb 7, 2025 | $133k |
| Feb 5, 2025 | Golden Robert Director | 20,000 0.28% of outstanding | $528k | Feb 6, 2025 | $64k |
| Dec 10, 2024 | Katz Michael David M.D. Director | 5,000 0.07% of outstanding | $128k | Dec 10, 2024 | none |
Transactions
The newest 50 of 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Kevin M O'Connor President | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 22,300 | 40 d ago |
| May 1, 2026 | Lisa A Diiorio FSVP & Chief Accounting Off. | MOption exercise Common Stock | +6,000 | $13.00 | $78k | 21,778 | May 5, 2026 |
| May 1, 2026 | Lisa A Diiorio FSVP & Chief Accounting Off. | FTax withholding Common Stock | -3,879 | $23.72 | $92k | 17,899 | May 5, 2026 |
| May 1, 2026 | Lisa A Diiorio FSVP & Chief Accounting Off. | MOption exercise Stock Optionsderivative | -6,000 | $0.00 | $0 | 0 | May 5, 2026 |
| Feb 20, 2026 | Lance P Burke SEVP & Chief Financial Officer | FTax withholding Common Stock | -187 | $21.98 | $4,110 | 28,955 | Feb 24, 2026 |
| Feb 20, 2026 | Joseph F Burns EVP & Chief Lending Officer | FTax withholding Common Stock | -188 | $21.98 | $4,132 | 11,505 | Feb 24, 2026 |
| Feb 20, 2026 | John P Vivona EVP & Chief Risk Officer | FTax withholding Common Stock | -95 | $21.98 | $2,088 | 5,152 | Feb 24, 2026 |
| Feb 20, 2026 | McClelland W Wilcox President | FTax withholding Common Stock | -421 | $21.98 | $9,254 | 100,677 | Feb 24, 2026 |
| Feb 20, 2026 | Michael P Puorro Chairman & CEO | FTax withholding Common Stock | -673 | $21.98 | $15k | 325,373 | Feb 24, 2026 |
| Feb 20, 2026 | Kevin Corbett EVP & Chief Credit Officer | FTax withholding Common Stock | -157 | $21.98 | $3,451 | 28,966 | Feb 24, 2026 |
| Feb 20, 2026 | Lisa A Diiorio FSVP & Chief Accounting Off. | FTax withholding Common Stock | -76 | $21.98 | $1,670 | 16,289 | Feb 24, 2026 |
| Feb 20, 2026 | Kevin Corbett EVP & Chief Credit Officer | FTax withholding Common Stock | -198 | $21.98 | $4,352 | 28,768 | Feb 24, 2026 |
| Feb 20, 2026 | Michael P Puorro Chairman & CEO | FTax withholding Common Stock | -680 | $21.98 | $15k | 324,693 | Feb 24, 2026 |
| Feb 20, 2026 | Lance P Burke SEVP & Chief Financial Officer | FTax withholding Common Stock | -220 | $21.98 | $4,836 | 28,735 | Feb 24, 2026 |
| Feb 20, 2026 | McClelland W Wilcox President | FTax withholding Common Stock | -536 | $21.98 | $12k | 100,141 | Feb 24, 2026 |
| Feb 20, 2026 | Lisa A Diiorio FSVP & Chief Accounting Off. | FTax withholding Common Stock | -83 | $21.98 | $1,824 | 16,206 | Feb 24, 2026 |
| Feb 20, 2026 | Lisa A Diiorio FSVP & Chief Accounting Off. | FTax withholding Common Stock | -428 | $21.98 | $9,407 | 15,778 | Feb 24, 2026 |
| Feb 20, 2026 | McClelland W Wilcox President | FTax withholding Common Stock | -624 | $21.98 | $14k | 99,517 | Feb 24, 2026 |
| Feb 20, 2026 | Michael P Puorro Chairman & CEO | FTax withholding Common Stock | -814 | $21.98 | $18k | 323,879 | Feb 24, 2026 |
| Feb 20, 2026 | Kevin Corbett EVP & Chief Credit Officer | FTax withholding Common Stock | -232 | $21.98 | $5,099 | 28,536 | Feb 24, 2026 |
| Feb 20, 2026 | Lance P Burke SEVP & Chief Financial Officer | FTax withholding Common Stock | -232 | $21.98 | $5,099 | 28,503 | Feb 24, 2026 |
| Feb 20, 2026 | Lance P Burke SEVP & Chief Financial Officer | FTax withholding Common Stock | -572 | $21.98 | $13k | 27,931 | Feb 24, 2026 |
| Feb 20, 2026 | McClelland W Wilcox President | FTax withholding Common Stock | -1,820 | $21.98 | $40k | 97,697 | Feb 24, 2026 |
| Feb 20, 2026 | Michael P Puorro Chairman & CEO | FTax withholding Common Stock | -2,216 | $21.98 | $49k | 321,663 | Feb 24, 2026 |
| Feb 20, 2026 | Kevin Corbett EVP & Chief Credit Officer | FTax withholding Common Stock | -600 | $21.98 | $13k | 27,936 | Feb 24, 2026 |
| Feb 5, 2026 | Robert Golden director | AGrant or award Common Stock | +1,592 | $0.00 | $0 | 26,268 | Feb 9, 2026 |
| Feb 5, 2026 | John R Sorrenti director | AGrant or award Common Stock | +1,592 | $0.00 | $0 | 47,209 | Feb 9, 2026 |
| Feb 5, 2026 | Elena Sisti director | AGrant or award Common Stock | +1,592 | $0.00 | $0 | 105,016 | Feb 9, 2026 |
| Feb 5, 2026 | John P Vivona EVP & Chief Risk Officer | AGrant or award Common Stock | +1,338 | $0.00 | $0 | 5,247 | Feb 9, 2026 |
| Feb 5, 2026 | Michael David Katz M.D. director | AGrant or award Common Stock | +1,592 | $0.00 | $0 | 152,202 | Feb 9, 2026 |
| Feb 5, 2026 | Philip A Okun director | AGrant or award Common Stock | +1,592 | $0.00 | $0 | 42,669 | Feb 9, 2026 |
| Feb 5, 2026 | Varkey Abraham director | AGrant or award Common Stock | +1,592 | $0.00 | $0 | 45,670 | Feb 9, 2026 |
| Feb 5, 2026 | Lance P Burke SEVP & Chief Financial Officer | AGrant or award Common Stock | +3,185 | $0.00 | $0 | 29,142 | Feb 9, 2026 |
| Feb 5, 2026 | Joseph F Burns EVP & Chief Lending Officer | AGrant or award Common Stock | +2,592 | $0.00 | $0 | 11,693 | Feb 9, 2026 |
| Feb 5, 2026 | Robert Golden director | SOpen-market sale Common Stockindirect: See Footnote 2 | -500 | $23.50 | $12k | 196,058 | Feb 9, 2026 |
| Feb 6, 2026 | Robert Golden director | SOpen-market sale Common Stockindirect: See Footnote 2 | -700 | $23.60 | $17k | 195,358 | Feb 9, 2026 |
| Feb 5, 2026 | Michael P Puorro Chairman & CEO | AGrant or award Common Stock | +10,945 | $0.00 | $0 | 326,046 | Feb 6, 2026 |
| Feb 5, 2026 | Metin Negrin director | AGrant or award Common Stock | +1,592 | $0.00 | $0 | 238,647 | Feb 6, 2026 |
| Feb 5, 2026 | Ahron H Haspel director | AGrant or award Common Stock | +1,592 | $0.00 | $0 | 29,035 | Feb 6, 2026 |
| Feb 5, 2026 | Kevin Corbett EVP & Chief Credit Officer | AGrant or award Common Stock | +2,198 | $0.00 | $0 | 29,123 | Feb 6, 2026 |
| Feb 5, 2026 | Lisa A Diiorio FSVP & Chief Accounting Off. | AGrant or award Common Stock | +1,062 | $0.00 | $0 | 16,365 | Feb 6, 2026 |
| Dec 1, 2025 | John P Vivona FSVP & Chief Risk Officer | FTax withholding Common Stock | -216 | $22.75 | $4,914 | 3,909 | Dec 3, 2025 |
| Dec 1, 2025 | Joseph F Burns EVP & Chief Lending Officer | FTax withholding Common Stock | -576 | $22.75 | $13k | 9,101 | Dec 2, 2025 |
| Nov 4, 2025 | Robert Golden director | SOpen-market sale Common Stockindirect: See Footnote 1 | -5,000 | $21.25 | $106k | 80,769 | Nov 6, 2025 |
| Aug 1, 2025 | Lance P Burke EVP & Chief Financial Officer | FTax withholding Common Stock | -540 | $20.81 | $11k | 25,957 | Aug 1, 2025 |
| May 8, 2025 | Robert Golden director | SOpen-market sale Common Stockindirect: See Footnote 1 | -1,829 | $23.65 | $43k | 201,558 | May 12, 2025 |
| May 8, 2025 | Robert Golden director | SOpen-market sale Common Stockindirect: See Footnote 2 | -5,000 | $22.83 | $114k | 47,771 | May 12, 2025 |
| May 9, 2025 | Robert Golden director | SOpen-market sale Common Stockindirect: See Footnote 1 | -5,000 | $23.09 | $115k | 196,558 | May 12, 2025 |
| May 9, 2025 | Robert Golden director | SOpen-market sale Common Stockindirect: See Footnote 2 | -5,000 | $23.06 | $115k | 42,771 | May 12, 2025 |
| May 6, 2025 | Robert Golden director | SOpen-market sale Common Stockindirect: See Footnote 1 | -1,708 | $23.04 | $39k | 203,387 | May 8, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Varkey Abrahamdirector
- Lance P BurkeSEVP & Chief Financial Officer
- Joseph F BurnsEVP & Chief Lending Officer
- Kevin CorbettEVP & Chief Credit Officer
- Lisa A DiiorioFSVP & Chief Accounting Off.
- Robert Goldendirector
- Ahron H Haspeldirector
- Michael David Katz M.D.director
- Metin Negrindirector
- Kevin M O'ConnorPresident
- Philip A Okundirector
- Michael P PuorroChairman & CEO
- Elena Sistidirector
- John R Sorrentidirector
- John P VivonaEVP & Chief Risk Officer
- McClelland W WilcoxPresident
Questions about HNVR
Answered from the filings on this page, as of the latest one.
Are insiders buying HNVR?
No. In the last 90 days no insider at Hanover Bancorp, Inc. /MD bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade HNVR on the open market?
Robert Golden (director) sold $28k of HNVR on Feb 5, 2026 and filed the Form 4 on Feb 9, 2026. InsiderTell scored 20 (weak).
How many insiders file Form 4 at Hanover Bancorp, Inc. /MD?
16 people have filed a Form 4 at Hanover Bancorp, Inc. /MD, among them Varkey Abraham (director), Lance P Burke (SEVP & Chief Financial Officer), Joseph F Burns (EVP & Chief Lending Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.